G. Aydogan Et Al. , "DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?," 20th Congress of European-Hematology-Association , vol.100, Vienna, Austria, pp.599, 2015
Aydogan, G. Et Al. 2015. DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?. 20th Congress of European-Hematology-Association , (Vienna, Austria), 599.
Aydogan, G., Salcioglu, Z., Akici, F., Sen, H., Tugcu, D., Gokce, M., ... Aycicek, A.(2015). DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L? . 20th Congress of European-Hematology-Association (pp.599). Vienna, Austria
Aydogan, G. Et Al. "DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?," 20th Congress of European-Hematology-Association, Vienna, Austria, 2015
Aydogan, G. Et Al. "DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?." 20th Congress of European-Hematology-Association , Vienna, Austria, pp.599, 2015
Aydogan, G. Et Al. (2015) . "DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?." 20th Congress of European-Hematology-Association , Vienna, Austria, p.599.
@conferencepaper{conferencepaper, author={G. Aydogan Et Al. }, title={DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?}, congress name={20th Congress of European-Hematology-Association}, city={Vienna}, country={Austria}, year={2015}, pages={599} }